Literature DB >> 32402353

Lung Cancer Staging.

Lynn T Tanoue1.   

Abstract

Anatomic staging is a critical step in evaluation of patients with lung cancer. Accurate identification of stage based on features of primary tumor (T), regional nodes (N), and metastatic disease (M) is fundamental to determining appropriate care. In this article, the TNM components of the anatomic staging system and a framework for description of lung cancer with multiple pulmonary sites of involvement are discussed. TNM combinations are grouped according to prognosis, with patient-level, tumor-level, and environment-level factors also influencing survival outcomes. Although the staging system does not include molecular and immunologic information, anatomic staging remains the common language for communicating extent of disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Lung cancer staging; Lymph node staging; Oligometastatic disease; TNM descriptors

Year:  2020        PMID: 32402353     DOI: 10.1016/j.ccm.2020.02.006

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  4 in total

1.  Prognostic value of PD-1, PD-L1 and P53 in patients with non-small cell lung cancer after postoperative adjuvant chemoradiotherapy.

Authors:  Aizhong Qu; Jiliang Han; Jianfeng Zhu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  DNA repair genes are associated with tumor tissue differentiation and immune environment in lung adenocarcinoma: a bioinformatics analysis based on big data.

Authors:  Jiayin Li; Jingxu Zhou; Jing Zhang; Zhiwei Xiao; Wenping Wang; Hanrui Chen; Lizhu Lin; Qiuye Yang
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 3.005

3.  Kruppel like factor 16 promotes lung adenocarcinoma progression by upregulating lamin B2.

Authors:  Xiaodan Jiao; Weinian Gao; Hongxin Ren; Yanning Wu; Tiezhi Li; Shujun Li; Hongjiang Yan
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis.

Authors:  Guanghua Li; Libo Wu; Jiaxing Yu; Siyang Zhai; Hailong Deng; Qiushi Wang
Journal:  J Oncol       Date:  2022-09-23       Impact factor: 4.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.